Disclosures for "Convergent Validity and Classification Agreement Between Traditional Cognitive Screening Instruments and a Novel, Electronic-based, Voice-recognition Cognitive Screening Tool"
-
-
Ms. Tretola has nothing to disclose.
-
-
Dr. Hall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
-
Dr. Alalsantro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for The Neurology Center.
-
Dr. Rosen has nothing to disclose.
-
-
The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.